| Medical and Health Sciences | 2021-2025 | 790 | US 274 | 99.82 |
| Cardiology and Cardiovascular Medicine | Lifetime | 836 | US 437 | 98.19 |
| Transplantation | Lifetime | 315 | US 141 | 89.52 |
| Surgery | 2021-2025 | 136 | US 58 | 99.18 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 129 | US 63 | 99.35 |
| Transplantation | 2021-2025 | 48 | US 21 | 91.78 |
| Transplantation: Methods and Outcomes | Lifetime | 185 | US 115 | 98.77 |
| Mechanical Circulatory Support Devices | Lifetime | 292 | US 182 | 98.68 |
| Cardiac Structural Anomalies and Repair | Lifetime | 391 | US 251 | 98.82 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 418 | US 220 | 98.29 |
| Viral Infections and Immunology Research | Lifetime | 522 | US 238 | 97.40 |
| Heart Failure Treatment and Management | Lifetime | 661 | US 310 | 97.68 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 422 | US 185 | 95.45 |
| Cardiovascular Issues in Pregnancy | Lifetime | 993 | US 427 | 93.51 |
| Potassium and Related Disorders | Lifetime | 821 | US 384 | 86.87 |
| Transplantation: Methods and Outcomes | 2021-2025 | 7 | US 4 | 99.48 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 15 | US 8 | 99.16 |
| Mechanical Circulatory Support Devices | 2021-2025 | 61 | US 30 | 98.82 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 81 | US 40 | 98.70 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 140 | US 66 | 99.01 |
| Heart Failure Treatment and Management | 2021-2025 | 90 | US 40 | 98.97 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 55 | US 30 | 96.80 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 88 | US 33 | 96.51 |
| Viral Infections and Immunology Research | 2021-2025 | 177 | US 56 | 93.30 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 482 | US 194 | 93.37 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 282 | US 70 | 89.13 |
| Diabetes Treatment and Management | 2021-2025 | 879 | US 283 | 91.29 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 823 | US 262 | 91.68 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 785 | US 265 | 85.51 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 443 | US 172 | 84.61 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 360 | US 112 | 84.60 |
| Pregnancy and Medication Impact | 2021-2025 | 543 | US 168 | 80.67 |
| Potassium and Related Disorders | 2021-2025 | 398 | US 150 | 71.60 |
| Polyomavirus and related diseases | 2021-2025 | 879 | US 288 | 71.59 |
| Organ and Tissue Transplantation Research | 2021-2025 | 576 | US 279 | 50.09 |
